Literature DB >> 21647092

Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.

Yu-Jie Hou1, Li-Wei Dong, Ye-Xiong Tan, Guang-Zhen Yang, Yu-Fei Pan, Zhong Li, Liang Tang, Min Wang, Qing Wang, Hong-Yang Wang.   

Abstract

Intrahepatic cholangiocellular carcinomas (ICCs) are usually fatal neoplasms originating from bile duct epithelia. However, many cholangiocarcinoma cells are shown to be resistant to chemotherapeutic drugs, which induce cell apoptosis. The role of autophagy and the therapeutic value of autophagy-associated genes are largely unknown in ICC. Here, we showed that autophagy was activated in nutrient starvation and xenograft cholangiocarcinoma cells. Furthermore, expression of autophagic genes and their autophagic activity were higher in clinical ICC specimens than that in normal cholangiocytes separated by laser capture microdissection. Inhibition of autophagy by autophagy inhibitors or siRNA, cholangiocarcinoma cells showed detention of proliferation and increase of apoptosis during nutrient starvation. In addition, autophagy inhibitor treatment or knockdown of beclin 1 suppressed tumor growth and sensitized ICC cells to chemotherapeutic agent-induced cell death. In conclusion, our data showed that autophagy is activated in ICC, and inactivation of autophagy may lead to cell apoptosis and enhance chemotherapy sensitivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647092     DOI: 10.1038/labinvest.2011.97

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  34 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

2.  Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.

Authors:  Michael R O'Dell; Jing Li Huang; Christa L Whitney-Miller; Vikram Deshpande; Paul Rothberg; Valerie Grose; Randall M Rossi; Andrew X Zhu; Hartmut Land; Nabeel Bardeesy; Aram F Hezel
Journal:  Cancer Res       Date:  2012-01-20       Impact factor: 12.701

Review 3.  [Precancerous and early stage cancer of the bile duct system].

Authors:  H-M Tautenhahn; S Brückner; F Rauchfuß; F Donndorf; M Ardelt; R Fahrner; A Tannapfel; U Settmacher
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

4.  GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Sonia Brun; Firas Bassissi; Cindy Serdjebi; Marie Novello; Jennifer Tracz; François Autelitano; Marie Guillemot; Philippe Fabre; Jérôme Courcambeck; Christelle Ansaldi; Eric Raymond; Philipe Halfon
Journal:  Invest New Drugs       Date:  2019-02-19       Impact factor: 3.850

5.  MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy.

Authors:  Zhenyou Zou; Linping Wu; Hanying Ding; Yang Wang; Yaqin Zhang; Xuejiao Chen; Xi Chen; Chen-Yu Zhang; Qipeng Zhang; Ke Zen
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

6.  Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.

Authors:  Wei Zhang; Qianyi Li; Chao Song; Lifeng Lao
Journal:  Tumour Biol       Date:  2014-11-27

7.  Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Authors:  Aaron R Hansen; Ian F Tannock; Arnoud Templeton; Eric Chen; Andrew Evans; Jennifer Knox; Amy Prawira; Srikala S Sridhar; Susie Tan; Francisco Vera-Badillo; Lisa Wang; Bradly G Wouters; Anthony M Joshua
Journal:  Oncologist       Date:  2019-04-05

Review 8.  Autophagy and cancer therapy.

Authors:  Andrew Thorburn; Douglas H Thamm; Daniel L Gustafson
Journal:  Mol Pharmacol       Date:  2014-02-26       Impact factor: 4.436

Review 9.  Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Gastroenterology       Date:  2013-10-15       Impact factor: 22.682

10.  HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.

Authors:  Estanislao Peixoto; Sujeong Jin; Kristen Thelen; Aalekhya Biswas; Seth Richard; Manuela Morleo; Adrian Mansini; Stephanie Holtorf; Fabrizia Carbone; Nunzia Pastore; Andrea Ballabio; Brunella Franco; Sergio A Gradilone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-04-27       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.